je.st
news
Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate
2016-03-14 19:19:38| Biotech - Topix.net
Novo Nordisk has secret weapons of sorts when it comes to entering the anti-obesity space. The first secret weapon is that the main ingredient in the anti-obesity drug Saxenda is the same ingredient, liraglutide, in the already successful diabetes drug Victoza.
Tags: not
added
market
novo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||